One in Seven Drug Supply Chain Issue Reports Tied to Drug Shortages
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic
Stay updated with breaking news from Integrated Data Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
Most phenylephrine products are coformulated with antihistamines or antitussives.
But reformulation of products containing OTC 'decongestant' could affect the supply chain
A wave of drug supply chain problems would occur if the FDA pulled cough and cold medications containing the active ingredient phenylephrine from shelves; lawmakers in 19 states are considering bills allowing medically assisted death; tuberculosis awareness is lagging as state and local health departments lack the resources to keep up with prevention and control efforts.